Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type by Burstedt, Marie SI & Mönestam, Eva
© 2010 Burstedt and Mönestam, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Ophthalmology
Clinical Ophthalmology 2010:4 147–154 147
Dovepress
open access to scientific and medical research
Open Access Full Text Article
submit your manuscript | www.dovepress.com
Dovepress 
O R i g i n A L   R e s e A R C h
self-reported quality of life in patients with retinitis 
pigmentosa and maculopathy of Bothnia type
Marie si Burstedt 
eva Mönestam
Department of Clinical sciences/
Ophthalmology, University of Umeå, 
sweden
Correspondence: Marie Burstedt  
Department of Clinical sciences/
Ophthalmology, University of Umeå  
s-901 85 Umeå, sweden 
Tel +46-90-7853774 
Fax +46-90-145997 
email marie.burstedt@ophthal.umu.se
Purpose: To assess vision-related quality-of-life subscales with objective measurements of 
visual function in patients affected with retinitis pigmentosa of Bothnia type (BD).
Methods: Forty-nine patients answered the NEI-VFQ-25 questionnaire. High- and low-contrast 
distance acuity (VA), near VA, and visual fields (VF) were measured. Weighted VA (WVA) and 
low-contrast (10%) VA (WLCVA), binocular VF areas, and central scotoma were calculated. 
Adjusted mean subscale scores were calculated and associations analyzed.
Results: Subscale scores for general, far, and near vision, social functioning, and color vision were 
lowest while general health, ocular pain, and mental health were highest in the BD phenotype. 
The correlations were substantial and similar for WVA, WLCVA, and near vision. The degree of 
measured VF impairment had few associations with the different adjusted subscale scores.
Conclusion: The NEI VFQ-25 subscales were well associated with clinical vision measures 
depending on VA. The progression of VF defects typical for the BD phenotype does not seem 
to affect the self-perceived quality of life, which might indicate adaptability to this type of pro-
gressive VF loss. The BD phenotype has a significant impact on multiple domains of daily life, 
but there are no signs of accelerating depression related to the increasing visual impairment.
Keywords: visual function, low vision, maculopathy, RP, Bothnia dystrophy, visual cycle, 
RLBP1
Introduction
The loss of visual function in retinal disorders is typically assessed by clinical tests 
such as visual acuity (VA), visual fields (VF), and electrophysiological methods. To 
increase the understanding of the patients’ situation and need it is also important to 
estimate the patients’ self-perceived visual function in different stages of the disease, 
in addition to standard ophthalmological measurements. Self-reported visual function 
and health related quality of life (VRQL) are also important to evaluate and compare 
the retinal degenerative diseases of different phenotypes.
Bothnia dystrophy (BD) is a clinically and genetically defined variant of autoso-
mal recessive retinitis pigmentosa (RP) associated with a missense mutation affecting 
the RLBP1 gene.1 There is a high prevalence of patients in northern Sweden, but RP 
phenotypes of the same gene have been described worldwide.2–5 The BD phenotype is 
characterized by early, severe night blindness, prolonged dark adaptation, and reduced 
macular function with decreasing VA in early adulthood. Fundus changes similar to 
retinitis punctata albescens, maculopathy, and peripheral retinal degeneration are 
found.6–8 Central and/or paracentral VF defects with relative to absolute scotomas, can 
be observed in the teens progressing to the peripheral borders with age.6 In BD the Clinical Ophthalmology 2010:4 148
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VF progression shows a complete or partial midperipheral ring 
scotoma resembling the pattern of VF progression described 
in autosomal recessive inherited RPs (pattern III),9 compared 
to the concentric loss of the VF in other phenotypes of RP.
The visual impairment of the BD patients affects their 
ability to perform various vision-specific functions of every-
day life. In a previous study associations between several 
objective measurements of visual function and self-assessed 
visual ability were investigated.10 It was found that age and 
weighted distance logMAR visual acuity (WVA) were sig-
nificantly associated with the 25-item National Eye Institute 
Visual Function Questionnaire (NEI-VFQ-25) composite 
score and that WVA alone was the strongest predictor of self-
reported assessment of total visual function in BD patients.
The purpose of this study was to associate the vari-
ous objective measurements of visual function with the 
patients’ self-assessment of vision measured by the VRQL-
questionnaire subscales. The aim was also to provide insight 
into the perceived visual function of this defined type of RP 
patients, and to describe the impact of vision loss caused 
by BD on everyday life, which previously has not been 
described. The patients in this study represent all ages and 
stages of the BD phenotype.
Patients and methods
Patients
Forty-nine patients, 21 men and 28 women, phenotypically 
and genetically affected with BD, were included in the study. 
All patients originated from the Västerbotten County, Sweden, 
and were evenly distributed in age and gender.10 The mean age 
of the patients was 49 years (SD = 20.8; range 5 to 80). A large 
proportion of the patients (39%) was legally blind (20/400 or 
worse), according to the WHO criteria.11 All patients were 
examined at the Eye Clinic, Umeå University Hospital, 
except for 5 participants (5/49) who had the examination at 
their home clinic because of too large geographical distance 
to travel. The ocular examination of the patients found no 
significant ocular disease other than BD.
Informed consents were obtained from all subjects. The 
study followed the tenets of the Declaration of Helsinki, and 
was approved by the Ethics Committee of Umeå University.
Tests of visual function
Monocular VA was tested by Early Treatment Diabetic 
Retinopathy Study (ETDRS) charts at a distance of 4 m. 
Participants who failed to read the largest letters at 4 m 
were tested at 1 m. Lighting conditions were standardized, 
using an “ETDRS” chart illuminator cabinet no 2425 
(Precision Vision®, La Salle IL, USA). VA was scored as 
the total number of letters read correctly and transformed to 
the logarithm of the minimum angle of resolution (logMAR) 
units. Patients with failure to read any letters were tested 
using counting fingers (CF), hand movements (HM), and 
light perception (P). For VA less than CF 0.5 m the follow-
ing arbitrary logMAR values were used CF in front of the 
eye = logMAR 2.2; HM = logMAR 2.3; P = logMAR 2.5 
and no light perception = logMAR 3.12
As binocular VA was not measured in this study, WVA 
was chosen to summarize the acuity data from both eyes of 
the patient into one value.13 The following method of calcula-
tion was used: VA of the better eye was weighted 0.75, VA 
of the worse eye 0.25, and the average of the two values was 
calculated, making up the WVA.
The five patients, who were examined at their home clinic, 
had their distance acuities tested with a Monoyer letter chart. 
Their decimal VAs were converted into a log scale using the 
method outlined by Holladay.14
Monocular low contrast VA (LCVA) was tested using 
Sloan letter logarithmic translucent contrast charts (10%) 
(Precision Vision®) at a distance of 4 m. Participants who 
failed to read the largest letters at 4 m were tested at 1 m. 
Lighting conditions were standardized as described above.
LCVA was scored as VA, ie, the total number of letters 
read correctly, and transformed to logarithm of the minimum 
angle of resolution (logMAR) units. Only 19 participants 
(19/49; 39%), predominantly in the younger ages (11 to 
60 years) were able to produce measurable results, when 
testing the LCVA chart. LogMAR = 3 was used for patients 
unable to read any letter on the 10% LCVA chart at a distance 
of 1 m). When summarizing the LCVA measurements from 
both eyes, weighted LCVA (WLCVA) was calculated using 
the same method as calculating WVA.
Binocular near vision was measured using the EDTRS 
near vision chart at a distance of 40 cm with best correction. 
The test distance was changed to 20 cm, if necessary.
Visual field examinations were performed monoculary 
with a Goldmann perimeter using the (V-4-e), and (II-4-e) 
targets. The binocular VF maps were produced by merging the 
monocular fields of each subject with BD, using the method 
described by Arditi.15 Central scotoma (target II:4:e) of the 
VF was measured in a similar fashion. The binocular VF 
areas and central relative scotoma areas were then measured 
and analyzed by a computer, using the software Scion Image, 
available at: http://www.scioncorp.com (Scion Corporation, 
Maryland, USA). With this method, in normal, healthy sub-
jects the areas of binocular VF diameters of 20°, 40° and Clinical Ophthalmology 2010:4 149
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70°, are 18.1 cm², 70.9 cm² and 221.7 cm², respectively. No 
measurable visual fields, using (II-4-e, V-4-e) targets, were 
found in eight patients (8/49; 16%), and in another 13 patients 
(13/49; 27%) only the largest (V-4-e) target was detected.
self-reported questionnaire  
on Vision-Related Quality of life
The patients rated their performance in a variety of everyday 
task of activities using the 25-item NEI-VFQ-25, which has 
been found to be both reliable and valid for use in patients 
with retinal disease.16,17 Subscales and items used in this 
study are shown in Table 1. Item responses were adjusted 
for directionality and changed so that high scores reflect 
patients with good vision/health. Scores were rated on a scale 
of 0 to 100, and subscale scores were created by averaging 
their adjusted item responses. Participants’ responses were 
excluded from specific items if they had stopped the activity 
for reasons other than poor eyesight.
The questionnaire was administered to all participants, 
and the patients completed it by themselves, unless their 
eyesight was too poor to enable reading. In these cases, the 
examiner MB, read the questionnaire for the patients, in a 
neutral, uniform manner. The five patients examined at their 
home clinic, had their questionnaires sent by mail (n = 3), or 
had an interview over the phone (n = 2).
statistical analysis
The mean value, standard deviation (SD) and the median 
for the overall NEI-VFQ score and for each subscale was 
computed. Spearman’s rank correlation analyses were used 
to assess the associations between the objective visual func-
tional results (WVA, WLCVA, binocular near vision, the 
merged areas of binocular V:4e target and II-4-e target, as 
well as the merged central scotoma area to the II:4e target), 
and the subscale responses from the VFQ-25 questionnaires. 
Monocular measurements of VA, LCVA were removed 
from the analyses as they did not provide any additional 
information.
The patients were grouped according to their results from 
each type of visual function measurement. The cut-off point 
for the WVA groups was “better than 20/400” and “20/400 or 
worse”, and for WLCVA it was “able to see the chart (10%)” 
and “not able to see the chart (10%)”. For binocular near VA 
the cut-off point was “able to read text” and “not able to read 
text”; for the merged areas of the binocular (V-4e target) the 
cut-off point was VF area of “200 cm²” and the VF area of 
“200 cm²”; and finally for the merged central scotoma area 
(II-4-e target) the patients were grouped into “no or small 
(20 cm²) centrally situated scotoma” (within 40°) of VF or 
“large/not measurable (20 cm²) centrally situated scotoma 
of the VF (within 40°). Mean subscale scores were adjusted 
for age and gender, using univariate analyses of variance with 
age and sex as covariates in the model, and then calculated 
for each group of functional loss.
All statistical analyses were carried out using SPSS 16.0 
(Statistical Package for the Social Sciences for MS Windows, 
SPSS Inc, Chicago, IL).
Results
In the sample of 49 patients, VA decreased with increasing 
age (Figure 1). Overall the females had better VA, but this dif-
ference was not statistically significant (data not shown).
The distribution of the NEI-VFQ-25 composite score 
and its subscales is presented in Table 2. Scores for general 
vision, near vision, far vision, social functioning and color 
vision were lowest, and those for general health, ocular pain, 
and mental health were highest.
The results for all subscales except mental health dete-
riorated significantly with increasing age (P values shown 
in Table 3).
Table 1 subscales used in the 25-item national eye institute Visual 
Function Questionnaire (nei-VFQ-25)
Subscale Item
general health Five level health rating
general vision six-level vision rating
Ocular pain eye pain keeps you from activities  
Amplitude of eye pain
near vision Reading ordinary print in newspapers  
Work or hobbies that require you to see well up 
close Finding something on a crowded shelf
Far vision Reading street or shop signs  
going down stairs in dim light  
going out to see movies, plays, sport events
social function seeing how people react to things you say  
Visiting other people
Mental health Worry about embarrassing myself because of 
eyesight  
Feel frustrated because of eyesight  
have less control of what i do because of eyesight
Role functioning Accomplish less because of vision  
Limited in length of activities because of vision
Dependency stay home because of eyesight  
Rely on others because of eyesight  
need help from others because of eyesight
Driving Driving during the day  
Driving during the night
Peripheral vision noticing objects off to the side
Colour vision Picking out and matching your clothesClinical Ophthalmology 2010:4 150
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Table 3 shows the Spearman’s correlation coefficients 
between the BD patients’ questionnaire responses by sub-
scales and WVA, WLCVA, binocular near vision, the merged 
VF areas of binocular V-4-e target, and the merged area of 
the central scotoma to the II-4-e target. Similar results were 
found between the merged binocular VF areas of the two 
targets measured V-4-e and II-4-e, therefore the correlations 
for the II-4-e target is not shown in Table 3.
The BD patients’ responses to a majority of the subscales 
used were significantly correlated with several clinical 
vision measures. Across the subscales the correlations were 
substantial and similar for WVA, WLCVA, and binocular 
near vision. The merged VF areas of binocular V-4-e target 
and the merged areas of the central scotoma (II-4-e target) 
also showed significant correlations with the questionnaire 
responses but there were fewer significant correlations and 
they were of lower magnitude.
General health was significantly associated with age but 
there were only weak associations with some of the vision 
measures (WVA, VA, binocular near VA), and the VF mea-
surements were not related at all.
The subscales mental health, role difficulty, and ocu-
lar pain had a similar pattern of correlations between the 
patients’ responses to the questionnaire items by subscales 
and the vision measures, with strong correlations for WVA, 
WLCVA, and binocular near VA and surprisingly few sig-
nificant correlations for the merged VF areas of binocular 
V:4e target and the merged central scotoma to the II:4e 
target areas.
The subscale social function was significantly correlated 
with all clinical vision measures.
Table 4 presents the mean subscale scores adjusted for 
age and gender in relation to the two groups of less or more 
functional loss for each type of visual function measurement. 
Patients with WVA of 20/400 or worse had significant more 
difficulty in all the NEI-VFQ subscales except for general 
health, ocular pain, mental health and role functioning 
compared with patients who had WVA better than 20/400. 
Patients not being able to see the LCVA10% chart showed 
a similar pattern as the WVA of 20/400 or worse, also with 
no significant difference for the subscales general health, 
ocular pain, mental health and role function.
The patients able to read had a better near vision subscale 
score adjusted for age and gender, compared with patients 
not being able to read, but surprisingly the results were not 
significantly different. The subscales far vision and social 
function were the only subscales with a significant differ-
ence between the groups “the patient can read text” or “can’t 
read text”.
For the results derived from the visual field analyses, 
the pattern was completely different. The only subscale in 
which the difference in subscale score was significantly 
lower for those patients with a VF area for object V:4e less 
than 200 cm² was general vision. There was no significant 
difference between the responses to all subscales regardless 
if the patients had “no or small centrally situated scotoma” 
(II-4-e) or “large/not measurable centrally situated scotoma 
(II-4-e) of the VF.
It is also important to notice that for the two measure-
ments, VF-area (V-4-e) and central scotoma (II-4-e), there 
were several subscales in which the patients with greater 
visual impairment had a better subscale score than patients 
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who were less impaired (figures shown in bold in Table 4). 
This was the case especially with subscales such as General 
Health, Ocular pain and Mental health.
Discussion
The BD phenotype expresses progressive maculopathy in 
early adulthood, in addition to the peripheral retinal degenera-
tive changes like retinal diseases of the RP type. To provide 
insight into the perceived visual function of this defined phe-
notype, and to describe the impact of vision loss caused by 
BD on everyday life, the NEI VFQ-25 questionnaire was used 
to capture an estimate of vision-targeted health-related qual-
ity of life from the patients’ perspective.16,17 The questionnaire 
provides an overall score as well as subscale scores which 
focus on content related to the impact of visual difficulties 
in everyday life, as well as relevant psychosocial domains 
such as role-difficulty, social function, and mental health.18 
The questionnaire is well designed psychometrically and is 
frequently used in research, which makes it easier to compare 
patients with different ocular diseases. Several types of visual 
function WVA, WLCVA, binocular VF area (II-4-e and V-4-e) 
have previously been shown to decrease with increasing age 
and progression of the BD phenotype.10
The BD patients’ responses to a majority of the NEI 
VFQ-25 subscales used were significantly correlated with 
several of the clinical vision measures especially those 
depending on central VA. As could be expected with the early 
and progressive decline of VA known in BD, the subscale 
scores of NEI VFQ-25 for general vision, near vision, far 
vision, and color vision were lowest (Table 2). These findings 
are in concordance with a study assessing everyday activities 
in patients with central retinal degeneration, and juvenile 
macular dystrophies.19 This study found highly significant 
correlations between activities involving central vision such 
as reading and the objective measures of central vision, ie, 
VA, and the area of central scotoma (II-4-e target).
In studies of RP patients, the visual function of the central 
retina, is known to change relatively slowly compared with 
more peripherally located retinal functions.20 On the other 
hand, patients with RP have also been shown to perceive 
difficulty in performing common tasks depending on vision, 
and this difficulty was strongly related to both VA as well 
as the VF-area.21
In the present study the BD patients obtained the highest 
scores (less impairment) for the subscales general health, 
ocular pain, and mental health. Previous studies have shown 
that older adults with sight-threatening eye diseases and 
visual impairment are prone to depression.22,23 Depression is 
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Table 3 Spearman’s correlation coefficients between the questionnaire subscale responses and weighted visual acuity (WVA) and 
low contrast (10%) weighted visual acuity (WLCVA), binocular near vision, the merged areas of binocular V:4e target and the merged 
central scotoma to the ii:4e target in patients with Bothnia dystrophy (the subscale Driving was not included because only 4 patients 
participated)
Age WVA WLCVA Bin VA near V:4 bin scot II:4 bin
general health -0.390(**) -0.333(*) -0.271 -0.319(*) 0.205 -0.191
P 0.006 0.019 0.071 0.035 0.166 0.203
general vision -0.714(**) -0.843(**) -0.733(**) -0.807(**) 0.838(**) -0.692(**)
P 0.000 0.000 0.000 0.000 0.000 0.000
Ocular pain -0.449(**) -0.363(*) -0.404(**) -0.362(*) 0.271 -0.345(*)
P 0.001 0.010 0.006 0.016 0.066 0.019
near vision -0.717(**) -0.835(**) -0.771(**) -0.824(**) 0.740(**) -0.702(**)
P 0.000 0.000 0.000 0.000 0.000 0.000
Distance vision -0.716(**) -0.811(**) -0.674(**) -0.830(**) 0.714(**) -0.656(**)
P 0.000 0.000 0.000 0.000 0.000 0.000
social functioning -0.643(**) -0.744(**) -0.663(**) -0.784(**) 0.654(**) -0.601(**)
P 0.000 0.000 0.000 0.000 0.000 0.000
Mental health -0.258 -0.368(**) -0.330(*) -0.371(*) 0.188 -0.085
P 0.074 0.009 0.027 0.013 0.206 0.576
Role difficult -0.363(*) -0.408(**) -0.346(*) -0.367(*) 0.268 -0.353(*)
P 0.010 0.004 0.020 0.014 0.068 0.016
Dependency -0.411(**) -0.564(**) -0.557(**) -0.564(**) 0.432(**) -0.272
P 0.003 0.000 0.000 0.000 0.002 0.068
Color vision -0.666(**) -0.742(**) -0.653(**) -0.731(**) 0.708(**) -0.653(**)
P 0.000 0.000 0.000 0.000 0.000 0.000
Peripheral vis -0.693(**) -0.750(**) -0.654(**) -0.756(**) 0.760(**) -0.623(**)
P 0.000 0.000 0.000 0.000 0.000 0.000
**Correlation significant at the 0.01 level (2-tailed).
*Correlation significant at the 0.05 level (2-tailed).
also associated with lower scores in distance vision activities 
and peripheral vision, ie, depressed patients expressed more 
difficulty.24
The psychosocially oriented VFQ subscales such as role 
difficulty, dependency, and mental health, are influenced 
by and reflect the presence of depression. For the subscales 
ocular pain, mental health and role functioning there was no 
significant difference in scores between BD-patients with 
more or less visual impairment. In fact, several subscales 
(Table 4) show better age and gender adjusted scores for 
patients with advanced BD and all subscales except men-
tal health deteriorated significantly with increasing age 
(Table 3). It has been shown that the longer the duration of 
perceived vision loss, the less it is associated with emotional 
distress.25 The reason for no signs of accelerating depression 
related to the increasing visual impairment in BD patients Clinical Ophthalmology 2010:4 153
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might well be that the patients have adjusted to their diagnosis 
to a high degree.
The BD patients’ overall responses to a majority of the 
subscales of NEI VFQ-25 were substantially and similarly 
associated with WVA, WLCVA, and binocular near vision 
(Table 3). Surprisingly, the merged VF areas (V-4-e target) 
and the merged areas of the central scotoma (II-4-e target) 
showed fewer significant associations of lower magnitude 
with the questionnaire responses. There was no significant 
difference in adjusted subscale scores for patients with or 
without extensive VF impairment except for the subscale 
General Vision (Table 4). Similarly, there was no difference 
in adjusted responses for patients with or without a centrally 
extensive scotoma (II-4-e target).
Measurements of the visual field may not be the best way 
to capture an estimate of vision-targeted health related qual-
ity of life from the BD patients’ perspective. The reason for 
this is not clear. A previous study of the BD phenotype has 
shown that the VF impairment begins with affection of the 
central and/or paracentral VF. The VF defects progress with 
time, finally affecting the peripheral borders of the VFs in 
the advanced disease of BD.6 We may speculate that the BD 
patients may actually perceive less impact of the midperiph-
eral VF defects in daily life compared to the more concentric 
loss of VF area in classical phenotypes of RP. The finding 
of low correlation of NEI VFQ-25 and VF impairment may 
also be an indication of an ability to adapt to this pattern of 
progressive VF loss in the BD phenotype. Further research of 
the phenotypical expression of mutations in the RLBP1 gene, 
found in this geographic area, can give additional knowledge 
of visual function outcome in this patient group.26
To conclude, the BD patients’ responses to a majority 
of the NEI VFQ-25 subscales were significantly correlated 
with several of the clinical vision measures especially those 
depending on central VA. On the contrary, the progression 
of VF defects typical for the BD phenotype does not seem to 
affect the self-perceived quality of life to a significant degree. 
This finding might be an indication of ability to adapt to this 
type of progressive VF loss of the BD phenotype. The BD 
phenotype has a significant impact on multiple domains of 
daily living, but there are no signs of worsening depression 
related to the increasing visual impairment.
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Table 4 Comparison of adjusted mean scale scores for weighted visual acuity, weighted low contrast acuity (10%), near visual acuity, 
visual field area V:4e, and scotomab
NEI-VFQ scale Weighted visual  
acuity
Weighted low  
contrast acuity (10%)
Near visual  
acuity
Visual field area  
(V-4-e)
Central scotoma 
(II-4-e)
20/400 
(n = 27)
20/400 
(n = 20)
Can see 
(n = 21)
Not able 
(n = 28)
Can read 
(n = 34)
Not able 
(n = 15)
200 cm² 
(n = 25)
200 cm² 
(n = 23 )
no/small 
scotoma 
(n = 26)
Large 
scotoma 
(n = 23)
general health 64.4 55.7 63.4 57.0 63.8 57.4 52.1 69.5 57.8 64.2
general vision 54.4a 34.6 56.2a  37.6 49.2 36.5 57.7a 33.7 47.6 44.5
Ocular pain 86.0 86.5 88.5 83.9 86.0 84.5 81.0 93.2 86.1 89.1
near vision 59.1a 35.9 63.8a 37.2 52.1 40.6 53.1 43.9 54.5 42.2
Far vision 50.5a 32.1 48.8 36.6 46.9a  30.2 45.2 39.3 41.4 43.3
social function 60.1a 34.1 60.2a 39.3 54.3a 34.0 57.6 39.3 51.4 46.2
Mental health 64.6 49.4 61.4 52.8 57.0 53.2 57.4 59.3 48.6 69.6
Role functioning 59.4 52.9 56.0 56.4 55.9 58.0 52.4 60.6 59.7 52.5
Dependency 60.5a 37.2 62.0a 38.9 52.5 43.3 60.4 39.1 52.7 46.7
Peripheral vision 61.5a 35.8 59.0a 41.1 54.6 39.0 59.2 40.5 59.0 41.3
Color vision 60.0a 33.3 61.0a 35.6 49.3 39.3 51.3 40.7 46.9 45.0
aThe difference between the groups is significant (P  0.05).
bAdjusted for age and gender.
Notes: Figures in boldface show a better adjusted mean subscale score for patients with greater visual impairment compared with those with less impairment.Clinical Ophthalmology 2010:4
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